Bank Of America Corp Neoleukin Therapeutics, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.68 - $0.91 $2,156 - $2,885	3,171 Added 0.27%	1,160,016 $962,000
Q1 2023 May 12, 2023	SELL	$0.5 - $0.72 $233,524 - $336,274	-467,048 Reduced 28.76%	1,156,845 $809,000
Q4 2022 Feb 10, 2023	BUY	$0.4 - $0.55 $579,212 - $796,417	1,448,031 Added 823.39%	1,623,893 $828,000
Q3 2022 Nov 14, 2022	SELL	$0.69 - $1.33 $8,402 - $16,196	-12,178 Reduced 6.48%	175,862 $112,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.25 $22,530 - $55,102	-24,490 Reduced 11.52%	188,040 $193,000
Q1 2022 May 16, 2022	BUY	$1.72 - $5.23 $35,440 - $107,764	20,605 Added 10.74%	212,530 $399,000
Q4 2021 Feb 08, 2022	BUY	$4.65 - $7.75 $18,446 - $30,744	3,967 Added 2.11%	191,925 $925,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $9.66 $22,651 - $36,167	3,744 Added 2.03%	187,958 $1.36 Million
Q2 2021 Sep 13, 2021	BUY	$9.23 - $13.12 $1.7 Million - $2.42 Million	184,214 New	184,214 $1.7 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.